ATE521358T1 - Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung - Google Patents

Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung

Info

Publication number
ATE521358T1
ATE521358T1 AT08703370T AT08703370T ATE521358T1 AT E521358 T1 ATE521358 T1 AT E521358T1 AT 08703370 T AT08703370 T AT 08703370T AT 08703370 T AT08703370 T AT 08703370T AT E521358 T1 ATE521358 T1 AT E521358T1
Authority
AT
Austria
Prior art keywords
functional gastrointestinal
propionic acid
acid bacteria
preventive
bacteria fermentation
Prior art date
Application number
AT08703370T
Other languages
English (en)
Inventor
Masayuki Uchida
Shigeru Yamato
Hajime Ariga
Hirotsugu Uehara
Tomofumi Amano
Keiko Morikubo
Kaori Yoshida
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Application granted granted Critical
Publication of ATE521358T1 publication Critical patent/ATE521358T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08703370T 2007-01-17 2008-01-17 Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung ATE521358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007007628 2007-01-17
PCT/JP2008/050515 WO2008088008A1 (ja) 2007-01-17 2008-01-17 消化管機能異常症予防及び／又は治療剤

Publications (1)

Publication Number Publication Date
ATE521358T1 true ATE521358T1 (de) 2011-09-15

Family

ID=39636009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08703370T ATE521358T1 (de) 2007-01-17 2008-01-17 Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung

Country Status (10)

Country Link
US (1) US9675647B2 (de)
EP (1) EP2110133B1 (de)
JP (1) JPWO2008088008A1 (de)
KR (1) KR101459166B1 (de)
CN (1) CN101646444B (de)
AT (1) ATE521358T1 (de)
CA (1) CA2675729C (de)
ES (1) ES2367880T3 (de)
HK (1) HK1140937A1 (de)
WO (1) WO2008088008A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102665738B (zh) * 2009-12-10 2015-07-01 株式会社明治 用于预防流感感染的组合物
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
JPWO2014163031A1 (ja) * 2013-04-01 2017-02-16 株式会社明治 即効性の整腸剤
EP3294308A4 (de) 2015-05-14 2019-03-06 University of Puerto Rico Verfahren zur wiederherstellung der biozönose von neugeborenen
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
WO2017164275A1 (ja) * 2016-03-24 2017-09-28 株式会社明治 口腔内環境改善用組成物
WO2018008895A1 (ko) 2016-07-08 2018-01-11 주식회사 엠디헬스케어 프로피오니박테리움 속 세균 유래 나노소포 및 이의 용도
KR101923969B1 (ko) 2016-07-08 2018-11-30 주식회사 엠디헬스케어 프로피오니박테리움 속 세균 유래 나노소포 및 이의 용도
US20240041949A1 (en) * 2020-12-09 2024-02-08 Meiji Co., Ltd. Composition comprising bacterium of the genus acidipropionibacterium or processed product thereof
CN117279966A (zh) 2021-06-29 2023-12-22 大塚化学株式会社 环氧树脂改性剂、含有其的环氧树脂组合物、由环氧树脂组合物构成的接合剂以及固化环氧树脂组合物而成的树脂固化物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3315826B2 (ja) 1994-04-26 2002-08-19 明治乳業株式会社 ビフィズス菌増殖促進組成物
EP1230920B1 (de) * 1999-10-19 2006-07-19 Meiji Dairies Corporation Verwendung von nahrungsmittel in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
CN1312285C (zh) * 2001-08-10 2007-04-25 明治乳业株式会社 制造1,4－二羟基－2萘甲酸的方法
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
JP2006501281A (ja) * 2002-09-26 2006-01-12 プロバイオヘルス・エルエルシー 油乳化プロバイオティックカプセル封入物のプレバイオティックおよび保存的使用
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
EP1738761A4 (de) 2004-04-13 2009-08-19 Meiji Dairies Corp Mittel zur prävention und/oder behandlung von entzündlichen darmerkrankungen

Also Published As

Publication number Publication date
EP2110133A1 (de) 2009-10-21
ES2367880T3 (es) 2011-11-10
CA2675729C (en) 2015-05-12
WO2008088008A1 (ja) 2008-07-24
CN101646444B (zh) 2013-11-06
US9675647B2 (en) 2017-06-13
EP2110133A4 (de) 2010-05-19
HK1140937A1 (en) 2010-10-29
CA2675729A1 (en) 2008-07-24
JPWO2008088008A1 (ja) 2010-05-13
US20100040698A1 (en) 2010-02-18
KR20090101961A (ko) 2009-09-29
KR101459166B1 (ko) 2014-11-07
EP2110133B1 (de) 2011-08-24
CN101646444A (zh) 2010-02-10

Similar Documents

Publication Publication Date Title
ATE521358T1 (de) Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung
JP6871304B2 (ja) ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
BR112017024777A2 (pt) uso de uma composiçao farmacêutica e de um antibiótico não absorvível para tratamento de transtorno do espectro autista referência cruzada a pedidos relacionados?
NO20092444L (no) Heteroarylamidderivater
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
EP2440210A4 (de) Verfahren zur behandlung von magen-darm-erkrankungen
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
WO2011044506A3 (en) Sulphone compounds for use in the treatment of obesity
Hwang et al. Immune disorders and its correlation with gut microbiome
SE1550189A1 (en) Therapeutic and prophylactic composition produced by microbiota
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
BR112014008511A2 (pt) composições nutricionais com fitonutrientes
MX2014005433A (es) Métodos y composiciones para modular bacterias gastrointestinales para promover la salud.
SG11201807500RA (en) Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria
BR112014031730A2 (pt) entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1
MX2014004719A (es) Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal.
EA201291441A1 (ru) Пробиотические штаммы для применения при улучшении состояния кишечной нервной системы
EA201190068A1 (ru) Композиция и способ лечения диабета
MX2009012197A (es) Metodos para tratamiento de ulceras en la piel.
TN2011000482A1 (en) Organic compounds and their uses
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
EP4008786A3 (de) Mirna-212/132-familie als therapeutisches target
EA201290158A1 (ru) Композиция и способ лечения диабета
EA201200428A1 (ru) Композиция и способ для лечения ожирения
EA201400319A1 (ru) Продукты и способы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties